Local: Los Angeles, CA  (change)

 | 

Join the Topix community today: 

Sign Up

 | 

Sign In

Advertisment
Biotech

Jul 21, 2008

Merck and Schering delay 2Q reports to afternoon

Schering-Plough Corp provided this undated file photo of the cholesterol-lowering drug Vytorin a product of a joint venture between pharmaceutical companies Merck & Co., and Schering-Plough Corp.

Leave a Comment

Comments

Type in your comments to post to the forum
Name
(appears on your post)
Comments
Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Biotech Discussions
Topic Updated Last By Comments
Claims administrator: Interim payments in $4.85... 1 hr Abby 27
Vioxx claimants rush to join $4.85B settlement ... (from Jan '08) 1 hr Abby 136
McCain-Palin Pairing: Ticket To Ride Or Ruin? 1 hr Sarah ROCKS 4
Study - no connection between measles, mumps, r... 2 hr DC tells it ... 14
Teva Announces Launch of Generic Zoloft (from Nov '06) 3 hr Tinkerbell 1099
Lexicon identifies potential new treatment for ... 4 hr saaid 1
Merck to fund Vioxx settlement in August 4 hr Jackson 128